208 related articles for article (PubMed ID: 34875132)
1. Towards precision medicine in lymphoid malignancies.
Bühler MM; Martin-Subero JI; Pan-Hammarström Q; Campo E; Rosenquist R
J Intern Med; 2022 Aug; 292(2):221-242. PubMed ID: 34875132
[TBL] [Abstract][Full Text] [Related]
2. Genomic profiling for clinical decision making in lymphoid neoplasms.
de Leval L; Alizadeh AA; Bergsagel PL; Campo E; Davies A; Dogan A; Fitzgibbon J; Horwitz SM; Melnick AM; Morice WG; Morin RD; Nadel B; Pileri SA; Rosenquist R; Rossi D; Salaverria I; Steidl C; Treon SP; Zelenetz AD; Advani RH; Allen CE; Ansell SM; Chan WC; Cook JR; Cook LB; d'Amore F; Dirnhofer S; Dreyling M; Dunleavy K; Feldman AL; Fend F; Gaulard P; Ghia P; Gribben JG; Hermine O; Hodson DJ; Hsi ED; Inghirami G; Jaffe ES; Karube K; Kataoka K; Klapper W; Kim WS; King RL; Ko YH; LaCasce AS; Lenz G; Martin-Subero JI; Piris MA; Pittaluga S; Pasqualucci L; Quintanilla-Martinez L; Rodig SJ; Rosenwald A; Salles GA; San-Miguel J; Savage KJ; Sehn LH; Semenzato G; Staudt LM; Swerdlow SH; Tam CS; Trotman J; Vose JM; Weigert O; Wilson WH; Winter JN; Wu CJ; Zinzani PL; Zucca E; Bagg A; Scott DW
Blood; 2022 Nov; 140(21):2193-2227. PubMed ID: 36001803
[TBL] [Abstract][Full Text] [Related]
3. LYmphoid NeXt-Generation Sequencing (LYNX) Panel: A Comprehensive Capture-Based Sequencing Tool for the Analysis of Prognostic and Predictive Markers in Lymphoid Malignancies.
Navrkalova V; Plevova K; Hynst J; Pal K; Mareckova A; Reigl T; Jelinkova H; Vrzalova Z; Stranska K; Pavlova S; Panovska A; Janikova A; Doubek M; Kotaskova J; Pospisilova S
J Mol Diagn; 2021 Aug; 23(8):959-974. PubMed ID: 34082072
[TBL] [Abstract][Full Text] [Related]
4. Novel precision medicine approaches and treatment strategies in hematological malignancies.
Rosenquist R; Bernard E; Erkers T; Scott DW; Itzykson R; Rousselot P; Soulier J; Hutchings M; Östling P; Cavelier L; Fioretos T; Smedby KE
J Intern Med; 2023 Oct; 294(4):413-436. PubMed ID: 37424223
[TBL] [Abstract][Full Text] [Related]
5. Precision diagnostics in lymphomas - Recent developments and future directions.
Mansouri L; Thorvaldsdottir B; Laidou S; Stamatopoulos K; Rosenquist R
Semin Cancer Biol; 2022 Sep; 84():170-183. PubMed ID: 34699973
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic molecular pathology of lymphoid malignancies.
Fend F; van den Brand M; Groenen PJ; Quintanilla-Martinez L; Bagg A
Virchows Arch; 2024 Feb; 484(2):195-214. PubMed ID: 37747559
[TBL] [Abstract][Full Text] [Related]
7. [Genetic dissection of the molecular mechanism of malignant lymphoma using advanced genomic technology].
Shingaki S; Kataoka K
Rinsho Ketsueki; 2022; 63(9):1058-1066. PubMed ID: 36198530
[TBL] [Abstract][Full Text] [Related]
8. A genetic profiling guideline to support diagnosis and clinical management of lymphomas.
Sánchez-Beato M; Méndez M; Guirado M; Pedrosa L; Sequero S; Yanguas-Casás N; de la Cruz-Merino L; Gálvez L; Llanos M; García JF; Provencio M
Clin Transl Oncol; 2024 May; 26(5):1043-1062. PubMed ID: 37672206
[TBL] [Abstract][Full Text] [Related]
9. The role of molecular biology in the diagnosis of lymphoid neoplasms.
Pizzi M; Gazzola A; Mannu C; Pileri SA; Sabattini E; Pileri SA
Front Biosci (Landmark Ed); 2014 Jun; 19(7):1088-104. PubMed ID: 24896338
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic, Prognostic, and Predictive Role of Next-Generation Sequencing in Mature Lymphoid Neoplasms.
Slack GW
Surg Pathol Clin; 2023 Jun; 16(2):433-442. PubMed ID: 37149368
[TBL] [Abstract][Full Text] [Related]
11. Practicing precision medicine with intelligently integrative clinical and multi-omics data analysis.
Ahmed Z
Hum Genomics; 2020 Oct; 14(1):35. PubMed ID: 33008459
[TBL] [Abstract][Full Text] [Related]
12. Whole genome profiling and other high throughput technologies in lymphoid neoplasms--current contributions and future hopes.
Campo E
Mod Pathol; 2013 Jan; 26 Suppl 1():S97-S110. PubMed ID: 23281439
[TBL] [Abstract][Full Text] [Related]
13. Transcriptomics and solid tumors: The next frontier in precision cancer medicine.
Tsimberidou AM; Fountzilas E; Bleris L; Kurzrock R
Semin Cancer Biol; 2022 Sep; 84():50-59. PubMed ID: 32950605
[TBL] [Abstract][Full Text] [Related]
14. Overview: A New Era of Cancer Genomics in Lymphoid Malignancies.
Iida S
Oncology; 2015; 89 Suppl 1():4-6. PubMed ID: 26551834
[TBL] [Abstract][Full Text] [Related]
15. Feasibility and clinical utility of comprehensive genomic profiling of hematological malignancies.
Fukuhara S; Oshikawa-Kumade Y; Kogure Y; Shingaki S; Kariyazono H; Kikukawa Y; Koya J; Saito Y; Tabata M; Yoshifuji K; Mizuno K; Miyagi-Maeshima A; Matsushita H; Sugiyama M; Ogawa C; Inamoto Y; Fukuda T; Sugano M; Yamauchi N; Minami Y; Hirata M; Yoshida T; Kohno T; Kohsaka S; Mano H; Shiraishi Y; Ogawa S; Izutsu K; Kataoka K
Cancer Sci; 2022 Aug; 113(8):2763-2777. PubMed ID: 35579198
[TBL] [Abstract][Full Text] [Related]
16. [Genetic studies on lymphoma].
Yamaguchi K; Kataoka K
Rinsho Ketsueki; 2021; 62(8):1121-1130. PubMed ID: 34497199
[TBL] [Abstract][Full Text] [Related]
17. A Brief Overview and Update on Major Molecular Genomic Alterations in Solid, Bone and Soft Tissue Tumors, and Hematopoietic As Well As Lymphoid Malignancies.
Zhang W; Yao J; Zhong M; Zhang Y; Guo X; Wang HY
Arch Pathol Lab Med; 2021 Nov; 145(11):1358-1366. PubMed ID: 34270703
[TBL] [Abstract][Full Text] [Related]
18. [Precision medicine for acute myeloid leukemia based on genomic profiling].
Sanada M
Rinsho Ketsueki; 2019; 60(7):847-853. PubMed ID: 31391376
[TBL] [Abstract][Full Text] [Related]
19. Genomics-Enabled Precision Medicine for Cancer.
Roos A; Byron SA
Cancer Treat Res; 2019; 178():137-169. PubMed ID: 31209844
[TBL] [Abstract][Full Text] [Related]
20. Molecular biology in the diagnosis and prognosis of solid and lymphoid tumors.
Lebovitz RM; Albrecht S
Cancer Invest; 1992; 10(5):399-416. PubMed ID: 1393689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
